These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15540780)

  • 41. Differential cytotoxic response in keloid fibroblasts exposed to photodynamic therapy is dependent on photosensitiser precursor, fluence and location of fibroblasts within the lesion.
    Mendoza J; Sebastian A; Allan E; Allan D; Mandal P; Alonso-Rasgado T; Bayat A
    Arch Dermatol Res; 2012 Sep; 304(7):549-62. PubMed ID: 22864934
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transferrin-conjugated liposome targeting of photosensitizer AlPcS4 to rat bladder carcinoma cells.
    Derycke AS; Kamuhabwa A; Gijsens A; Roskams T; De Vos D; Kasran A; Huwyler J; Missiaen L; de Witte PA
    J Natl Cancer Inst; 2004 Nov; 96(21):1620-30. PubMed ID: 15523091
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sensitization and photodynamic therapy (PDT) of gastrointestinal tumors with 5-aminolaevulinic acid (ALA) induced protoporphyrin IX (PPIX). A pilot study.
    Mĺkvy P; Messmann H; Regula J; Conio M; Pauer M; Millson CE; MacRobert AJ; Bown SG
    Neoplasma; 1995; 42(3):109-13. PubMed ID: 7637818
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Protoporphyrin IX formation after application of methyl aminolevulinate on the face and scalp with and without prior curettage.
    Heerfordt IM; Bieliauskiene G; Wulf HC
    Photodiagnosis Photodyn Ther; 2018 Jun; 22():155-157. PubMed ID: 29601904
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetics of the photosensitizers aminolevulinic acid and aminolevulinic acid hexylester in oro-facial tumors embedded in the chorioallantois membrane of a hen's egg.
    Hoppenheit C; Hüttenberger D; Foth HJ; Spitzer WJ; Reichert TE; Müller-Richter UD
    Cancer Biother Radiopharm; 2006 Dec; 21(6):569-78. PubMed ID: 17257072
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and safety of photodynamic therapy for recurrent, high grade nonmuscle invasive bladder cancer refractory or intolerant to bacille Calmette-Guérin immunotherapy.
    Lee JY; Diaz RR; Cho KS; Lim MS; Chung JS; Kim WT; Ham WS; Choi YD
    J Urol; 2013 Oct; 190(4):1192-9. PubMed ID: 23648222
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fluorescence photobleaching of ALA-induced protoporphyrin IX during photodynamic therapy of normal hairless mouse skin: the effect of light dose and irradiance and the resulting biological effect.
    Robinson DJ; de Bruijn HS; van der Veen N; Stringer MR; Brown SB; Star WM
    Photochem Photobiol; 1998 Jan; 67(1):140-9. PubMed ID: 9477772
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy.
    Loh CS; MacRobert AJ; Bedwell J; Regula J; Krasner N; Bown SG
    Br J Cancer; 1993 Jul; 68(1):41-51. PubMed ID: 8318419
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A quantitative comparison of 5-aminolaevulinic acid- and methyl aminolevulinate-induced fluorescence, photobleaching and pain during photodynamic therapy.
    Valentine RM; Ibbotson SH; Brown CT; Wood K; Moseley H
    Photochem Photobiol; 2011; 87(1):242-9. PubMed ID: 21077899
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Photodynamic therapy with PAD-S31, a new hydrophilic chlorin photosensitizer, in an orthotopic rat bladder tumor model.
    Asanuma H; Arai T; Morimoto Y; Kawauchi S; Satoh H; Seguchi K; Kikuchi M; Murai M
    J Urol; 2005 Nov; 174(5):2016-21. PubMed ID: 16217385
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fluorescence diagnosis of bladder cancer: a novel in vivo approach using 5-aminolevulinic acid (ALA) dendrimers.
    François A; Battah S; MacRobert AJ; Bezdetnaya L; Guillemin F; D'Hallewin MA
    BJU Int; 2012 Dec; 110(11 Pt C):E1155-62. PubMed ID: 22883132
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Determination of the maximal tumor:normal bladder ratio after i.p. or bladder administration of 5-aminolevulinic acid in Fischer 344 rats by fluorescence spectroscopy in situ.
    Bisson JF; Christophe M; Padilla-Ybarra JJ; Notter D; Vigneron C; Guillemin F
    Anticancer Drugs; 2002 Sep; 13(8):851-7. PubMed ID: 12394271
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Photodynamic therapy of prostate cancer by means of 5-aminolevulinic acid-induced protoporphyrin IX - in vivo experiments on the dunning rat tumor model.
    Zaak D; Sroka R; Stocker S; Bise K; Lein M; Höppner M; Frimberger D; Schneede P; Reich O; Kriegmair M; Knüchel R; Baumgartner R; Hofstetter A
    Urol Int; 2004; 72(3):196-202. PubMed ID: 15084761
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of 3 different light doses in the treatment of actinic keratosis with 5-aminolevulinic acid photodynamic therapy: a randomized, observer-blinded, intrapatient, comparison study.
    Radakovic-Fijan S; Blecha-Thalhammer U; Kittler H; Hönigsmann H; Tanew A
    J Am Acad Dermatol; 2005 Nov; 53(5):823-7. PubMed ID: 16243131
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intravesical instillation of 5-aminolevulinic acid: the fluorescent metabolite is limited to urothelial cells.
    Steinbach P; Kriegmair M; Baumgartner R; Hofstädter F; Knüchel R
    Urology; 1994 Nov; 44(5):676-81. PubMed ID: 7974943
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The influence of hypoxia and pH on aminolaevulinic acid-induced photodynamic therapy in bladder cancer cells in vitro.
    Wyld L; Reed MW; Brown NJ
    Br J Cancer; 1998 May; 77(10):1621-7. PubMed ID: 9635837
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tissue responses to hexyl 5-aminolevulinate-induced photodynamic treatment in syngeneic orthotopic rat bladder cancer model: possible pathways of action.
    Arum CJ; Gederaas OA; Larsen EL; Randeberg LL; Hjelde A; Krokan HE; Svaasand LO; Chen D; Zhao CM
    J Biomed Opt; 2011 Feb; 16(2):028001. PubMed ID: 21361708
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro evaluation of the cytotoxic and mutagenic potential of the 5-aminolevulinic acid hexylester-mediated photodynamic therapy.
    Zenzen V; Zankl H
    Mutat Res; 2004 Jul; 561(1-2):91-100. PubMed ID: 15238234
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fluorescence detection and depletion of T47D breast cancer cells from human mononuclear cell-enriched blood preparations by photodynamic treatment: Basic in vitro experiments towards the removal of circulating tumor cells.
    Ziegler VG; Knaup J; Stahl D; Krammer B; Plaetzer K
    Lasers Surg Med; 2011 Sep; 43(7):548-56. PubMed ID: 22057482
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fluorescence kinetics of protoporphyrin-IX induced from 5-ALA compounds in rabbit postballoon injury model for ALA-photoangioplasty.
    Kwon OC; Yoon HJ; Kim KH; Kim HT; Yoon YH; Kim JK
    Photochem Photobiol; 2008; 84(5):1209-14. PubMed ID: 18363621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.